|
RNF114 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.135570E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.603780E-02 |
| Normal-vs-Stage2 |
1.538970E-01 |
| Normal-vs-Stage3 |
2.990300E-04 |
| Normal-vs-Stage4 |
2.04159999999121E-05 |
| Stage1-vs-Stage2 |
9.242400E-01 |
| Stage1-vs-Stage3 |
5.119700E-02 |
| Stage1-vs-Stage4 |
3.861300E-03 |
| Stage2-vs-Stage3 |
1.793390E-01 |
| Stage2-vs-Stage4 |
4.995600E-02 |
| Stage3-vs-Stage4 |
3.374800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.143900E-03 |
| Normal-vs-AfricanAmerican |
9.016000E-02 |
| Normal-vs-Asian |
3.286000E-01 |
| Caucasian-vs-AfricanAmerican |
8.691400E-01 |
| Caucasian-vs-Asian |
1.687400E-01 |
| AfricanAmerican-vs-Asian |
4.314600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.788800E-04 |
| Normal-vs-Female |
3.604800E-03 |
| Male-vs-Female |
2.436400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.737700E-02 |
| Normal-vs-Age(41-60Yrs) |
5.780000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.6198999999939E-05 |
| Normal-vs-Age(81-100Yrs) |
1.715670E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.979000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.881250E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.788390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.504300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.521200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.084400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.259200E-03 |
| Classical-VS-Follicular |
8.681700E-02 |
| Classical-VS-Other |
8.212200E-01 |
| Classical-VS-Normal |
4.067900E-02 |
| Tall-VS-Follicular |
3.135200E-01 |
| Tall-VS-Other |
4.106200E-01 |
| Tall-VS-Normal |
1.594070E-04 |
| Follicular-VS-Other |
5.950600E-01 |
| Follicular-VS-Normal |
2.444800E-03 |
| Other-VS-Normal |
8.780800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.441900E-03 |
| Normal-vs-N1 |
1.026620E-04 |
| N0-vs-N1 |
3.926100E-02 |
|
|
